BRYON SAWYER: Open Payments
NPI 1255975405 · AMORY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 34 payments from 8 companies in 2025. Trend: 2023 $16 · 2024 $125 · 2025 $589
Food & beverage: $571Honoraria: $18
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $170 |
| AstraZeneca Pharmaceuticals LP | 9 | $152 |
| Amgen Inc. | 6 | $99 |
| Lilly USA, LLC | 4 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Dexcom, Inc. | 1 | $24 |
| Becton, Dickinson and Company | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
Products named: FARXIGA, JARDIANCE, EVENITY, Ozempic, Rybelsus, AIRSUPRA, Dexcom G6 Transmitter, REPATHA.
Industry payments across MS — which companies pay providers there.
